3+ day, 15+ hour ago   (293+ words) Sept 10 (Reuters) – Biohaven said on Thursday the U.S. FDA had imposed a partial clinical hold, pausing new patient enrollment in trials of its experimental epilepsy drug ​after rodent findings, sending its shares down more than ‌15% in early trading. • The U....

3+ day, 15+ hour ago   (331+ words) By Pete Schroeder and Michelle Price WASHINGTON, Sept 10 (Reuters) – Better Markets, a Washington nonprofit that advocates for Wall Street reforms, sued the U.S. Federal Reserve and its top regulatory official on Thursday, alleging the central bank mishandled a sweeping overhaul…...

4+ day, 16+ hour ago   (237+ words) BEIJING, Sept 9 (Reuters) – Tencent-backed AI chipmaker Shanghai Enflame Technology will make its Shanghai stock market debut on September 11, an ​exchange filing showed on Wednesday. Enflame, one ‌of China’s leading AI chip startups known locally as the “four little GPU dragons…...

4+ day, 16+ hour ago   (560+ words) VENICE, Sept 9 (Reuters) – A film shot when war between Russia and Ukraine seemed unthinkable finally hit Venice on Wednesday, with director Ilya Khrzhanovsky unveiling “DAU”, a 20-year project that has generated both fascination and controversy. Ukraine’s government has objected to…...

4+ day, 16+ hour ago   (59+ words) Y100 WNCY Republican lawmakers criticize Ford business ties to China WASHINGTON, Sept 9 (Reuters) – Republicans in Congress on Wednesday ​joined criticism of Ford Motor over its business ties to Chinese firms after ​Transportation ⁠Secretary Sean Duffy ⁠sharply criticized the No. 2 U.S....

5+ day, 8+ hour ago   (317+ words) Sept 8 (Reuters) – Shares of Dyne Therapeutics and Sarepta slumped on Tuesday after Novartis’ treatment for a muscle-wasting disorder failed in a trial, fueling investor concerns ​about the prospects of similar therapies for the tough-to-treat ‌rare disease. Dyne’s stock led declines…...

5+ day, 17+ hour ago   (257+ words) Sept 8 (Reuters) – Bristol Myers Squibb said on Tuesday its experimental cell therapy showed a high overall response rate in a mid-stage trial, ​in patients with a hard-to-treat form of ‌blood cancer. The study evaluated the therapy, called arlocabtagene autoleucel, or…...

6+ day, 49+ min ago   (374+ words) SAN FRANCISCO, Sept 7 (Reuters) – ASML, the Dutch chip manufacturing tool company, said it plans to work together with its major customers to produce its most advanced tools for developing the ​kind of large data center chips designed by Nvidia and…...

6+ day, 16+ hour ago   (191+ words) Sept 7 (Reuters) – Novo Nordisk said on Monday it had halted two additional trials of its ​experimental cardiovascular drug ziltivekimab, further ‌denting the Danish drugmaker’s efforts to diversify beyond its blockbuster obesity and diabetes franchise. In July, Novo said ziltivekimab failed…...

1+ week, 50+ min ago   (452+ words) Sept 7 (Reuters) – European shares edged lower on Monday as oil prices climbed after a fresh exchange of strikes between the United States and Iran, fuelling inflation concerns and bolstering expectations that the European Central Bank may need to keep ​raising…...